Diabetes Care Devices - Brunei Darussalam

  • Brunei Darussalam
  • In Brunei Darussalam, revenue in the Diabetes Care Devices market market is projected to reach US$1.14m in 2024.
  • Revenue in this sector is expected to exhibit an annual growth rate (CAGR 2024-2029) of 11.45%, leading to a market volume of US$1.96m by 2029.
  • In a global context, the majority of revenue will be generated the United States, which is anticipated to reach US$11,710.00m in 2024.
  • Brunei Darussalam is witnessing a growing adoption of innovative diabetes care devices, driven by increasing awareness and government initiatives aimed at enhancing chronic disease management.

Key regions: Netherlands, Japan, France, Italy, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Diabetes Care Devices Market in Brunei Darussalam is witnessing considerable growth, fueled by the increasing prevalence of diabetes, advancements in technology, and heightened awareness of the importance of effective diabetes management among the population.

Customer preferences:
In Brunei Darussalam, there is a noticeable shift towards personalized diabetes management tools, as consumers increasingly prioritize devices that offer tailored solutions to their unique health needs. The rising demand for user-friendly, connected devices reflects a growing tech-savvy population, particularly among younger demographics. Additionally, cultural emphasis on family health encourages collective monitoring, leading to increased interest in family-oriented diabetes care devices. As lifestyles evolve, the integration of mobile health applications and telehealth services is becoming essential for managing diabetes effectively.

Trends in the market:
In Brunei Darussalam, the Diabetes Care Devices Market is experiencing a surge in demand for advanced glucose monitoring systems, driven by a growing awareness of diabetes management. This trend is marked by the adoption of continuous glucose monitors (CGMs) and insulin delivery systems that offer real-time data and automation. The integration of mobile applications for data tracking and analytics is also gaining momentum, reflecting a shift towards data-driven healthcare. This evolution presents opportunities for manufacturers and healthcare providers to innovate and enhance patient engagement, ultimately leading to improved health outcomes and a more proactive approach to diabetes care.

Local special circumstances:
In Brunei Darussalam, the Diabetes Care Devices Market is shaped by a unique blend of cultural factors and regulatory support. The country's emphasis on healthy lifestyles, influenced by its Islamic values, promotes awareness of diabetes management. Additionally, Brunei's robust healthcare system and government initiatives aimed at reducing non-communicable diseases foster an environment conducive to adopting advanced medical technologies. The limited population allows for targeted health campaigns, enhancing patient education and engagement, which further drives demand for innovative diabetes care solutions.

Underlying macroeconomic factors:
The Diabetes Care Devices Market in Brunei Darussalam is significantly influenced by macroeconomic factors such as national economic stability, government fiscal policies, and global healthcare trends. The country's strong economic performance, supported by oil and gas revenues, enables substantial investment in healthcare infrastructure and technology. Furthermore, government initiatives aimed at improving public health and reducing the burden of diabetes through subsidies and health programs create a favorable environment for diabetes care innovations. Global trends, including the rise in diabetes prevalence and advancements in medical technology, also contribute to the market's growth by encouraging local adoption of cutting-edge diabetes management devices.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)